Laryngeal preservation: What is the best treatment strategy?

Current Oncology Reports

Volumn 6, Issue 3, 2004, Pages 167-169

  Hanna, Ehab Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFORMITY; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; METASTASIS; NOTE; OUTCOMES RESEARCH; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL INTERACTION; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 5444252855     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-004-0044-z     Document Type: Note

References (5)

1. Terrell JE, Fisher SG, Wolf GT: Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 1998, 124:964-971.
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991, 324:1685-1690.
3. Lefebvre JL, Chevalier D, Luboinski B, et al.: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996, 88:890-899.
4. Forastiere AA, Goepfert H, Maor M, et al.: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003, 349: 091-2098.
5. Hanna E, Shrieve DC, Ratanatharathorn V, et al.: A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res 2001, 61:2376-2380.